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ABSTRACT
Investigation of the genetic architecture of gene ex-
pression traits has aided interpretation of disease
and trait-associated genetic variants; however, key
aspects of expression quantitative trait loci (eQTL)
study design and analysis remain understudied. We
used extensive, empirically driven simulations to ex-
plore eQTL study design and the performance of
various analysis strategies. Across multiple testing
correction methods, false discoveries of genes with
eQTLs (eGenes) were substantially inflated when
false discovery rate (FDR) control was applied to
all tests and only appropriately controlled using hi-
erarchical procedures. All multiple testing correc-
tion procedures had low power and inflated FDR
for eGenes whose causal SNPs had small allele fre-
quencies using small sample sizes (e.g. frequency
<10% in 100 samples), indicating that even mod-
erately low frequency eQTL SNPs (eSNPs) in these
studies are enriched for false discoveries. In sce-
narios with ≥80% power, the top eSNP was the true
simulated eSNP 90% of the time, but substantially
less frequently for very common eSNPs (minor allele
frequencies >25%). Overestimation of eQTL effect
sizes, so-called ‘Winner’s Curse’, was common in low
and moderate power settings. To address this, we
developed a bootstrap method (BootstrapQTL) that
led to more accurate effect size estimation. These
insights provide a foundation for future eQTL stud-
ies, especially those with sampling constraints and
subtly different conditions.
INTRODUCTION
Genome-wide association studies (GWAS) have identified
thousands of genetic variants associated with complex phe-
notypes (1) and the vast majority of genome-wide signifi-
cant SNPs are located in non-coding region (2), making in-
terpretation challenging. Integration of gene expression and
genetic variation is a ubiquitous approach for uncovering
genetic regulatory effects and their ramifications for path-
ways relevant to human diseases and traits (3–6), and in-
deed trait-associated SNPs have been found to be enriched
for expression quantitative trait loci (eQTL) effects (7).
Yet, while eQTL analysis has become a focus of func-
tional genomics, the lack of a strong evidence base for eQTL
study design leaves fundamental questions unanswered. In
particular, while more andmore eQTLs reach statistical sig-
nificance, the true proportion of false discoveries and the
accuracy of their effect size estimates have not yet been well
characterized. A seminal early study compared multiple
testing correction methods for detecting eQTLs (including
Bonferroni correction, false discovery rate (FDR) control
and permutation) using HapMap data; however, estimates
of FDR and sensitivity are not possible without knowledge
of all true eQTLs in the data (8). Previous eQTL simulations
are typically part of new methodologies, yet these simula-
tions have been limited in their reflection of real data. Geno-
type data have typically been simulatedwith a narrowminor
allele frequency (MAF) range assuming Hardy–Weinberg
equilibrium (e.g. MAF 30% in (9), 5 and 20% in (10), 40%
in (11)), thus they have not captured realistic patterns of ge-
netic variation, especially linkage disequilibrium (LD) com-
plexity. Furthermore, MAFs at 1% or greater are typically
utilized for eQTL analysis (Supplementary Table S1). Oth-
ers have simulated only a fixed sample size (11–13). Typi-
cally, eQTL studies have sample sizes of 50 to 1000, with
the accessibility of the tissue or condition amajor determin-
ing factor (Supplementary Table S1). A recent trans-eQTL
study performed in whole blood had a size of 5257 sam-
ples (6) and a study combined data for 2116 whole blood
samples to identify context-specific eQTLs (14). Perhaps the
exemplar multiple human tissue resource, the Genotype-
Tissue Expression (GTEx) project (15), comprises 44 tissues
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with a sample size range of 70–361 in its V6p data release
(16).
While studies have generally converged on linear regres-
sion or linear mixed models for eQTL detection, the mul-
tiple testing correction approach is still a source of sub-
stantial variability among studies. Various approaches are
available for minimizing type I errors. Often criticized as
too conservative, particularly with complex LD patterns,
the Bonferroni correction aims to control the familywise er-
ror rate (the probability of making any type I error) by set-
ting the significance level at α/N, where  is the desired sig-
nificance level (0.05 conventionally) andN is the number of
tests. FDR-controlling procedures, which aim to control the
expected proportion of false discoveries among all rejected
null hypotheses, are generally considered to provide a bet-
ter balance between false positives and false negatives. Ben-
jamini and Hochberg (BH) proposed a procedure (17) as-
suming each statistical test is independent, which is not the
case due to LD. Benjamini and Yekutieli (BY) modified the
FDR procedure to one which, while more conservative, ac-
commodates correlation structure between statistical tests
(18). The q-value FDR-controlling approach from Storey
and Tibshirani (ST) estimates the proportion of hypotheses
that are truly null (π0), while the BH procedure assumes π0
= 1, which makes ST less conservative than the BH proce-
dure (19).
Other approaches have been proposed to deal with mul-
tiple testing specifically for eQTL studies. Locus-restricted
permutation testing is widely used to obtain empirical null
distributions. To achieve this, sample labels are randomly
shuffled, while keeping genotype data constant, with asso-
ciation tests performed at each permutation step. For each
gene, the best SNP association at each permutation is kept
to generate an empirical null distribution of minimum P-
values, from which permutation test P-values are calculated
for each cis-SNP. Thousands of permutations are required
to achieve accurate results, thus there is a high computa-
tional cost. Approximations have been investigated for cal-
culating permutation P-values, such as those in FastQTL
(20) and MVN (21). For example, FastQTL provides an
option to approximate the tail of the empirical null distri-
butions of P-values using a beta distribution thereby re-
ducing the number of permutations required (20). In addi-
tion to permutation tests, eigenMT proposed by Davis et al.
(22) adjusts P-values in shorter time. The number of inde-
pendent tests (typically SNPs) for each gene is estimated
by eigenMT using a genotype correlation matrix, then a
Bonferroni procedure is applied (22). Both FastQTL and
eigenMT account for LD structure among local variants.
Recently, hierarchical procedures, such as TreeQTL (23),
have been proposed, which first control for multiple testing
of variants at each gene, before controlling for multiple test-
ing across all genes. Taken together, with many correction
methods available, it is not clear which method is optimal
for eQTL mapping nor what their respective performances
are for genetic variants with difference characteristics (allele
frequency, effect size etc.).
Effect size estimation for eQTLs represents a more com-
plex and less explored problem, yet its importance is in-
creasing as comparison of eQTLs across tissues, experimen-
tal conditions and meta-analyses becomes more common.
Figure 1. Flowchart of eQTL simulation study.
Furthermore, prediction of tissue-specific gene expression
from genotypes, for example using the tool PrediXcan (24),
is critically dependent on effect size estimation, particularly
cis-eQTL effect sizes obtained from analyses of GTEx and
other studies. Conversely, a method that predicts genotypes
at eQTL SNPs (eSNPs) based on measured gene expression
levels has also been proposed (25).
A well-recognized and pervasive phenomenon in GWAS
is ‘Winner’s Curse’ (26–29), an ascertainment bias where
the true genetic effect is smaller than its estimate within
the discovery cohort. Notably, a recent paper from Palmer
and Pe’er systematically evaluated summary statistics from
100 previously published quantitative trait studies and
showed that Winner’s Curse was a key reason for the non-
replicability of significant loci (30). Using a maximum like-
lihood method, they showed that correction for Winner’s
Curse improved replication (30), yet these estimators, based
on summary statistics, were shown to over-correct Winner’s
Curse and the downward bias was larger when the sam-
ple size was small. Palmer and Pe’er definitively established
the QTL study-level ramifications of Winner’s Curse, yet to
our knowledge no study has comprehensively investigated
Winner’s Curse for eQTLs or other QTLs of the expressed
genome using individual-level data. To rigorously evaluate
each locus and design follow-up experiments, it is impor-
tant that we understand Winner’s Curse in the context of
sample size, allele frequency and the estimated effect size,
as well as design methods for adjusting effect sizes during
eQTL discovery. As with other studies (31,32) evaluating
key genome-wide study design questions, large-scale simu-
lation, where the true causal variant(s) and their effect(s)
are known from the outset, is a critical tool for quantifying
the relative performance of different approaches in diverse
settings.
Here, we used extensive simulations of realistic LD pat-
terns of human genetic variation and matched gene expres-
sion to investigate how various scenarios, including differ-
ent sample sizes, allele frequencies and genetic effect sizes,
influence statistical power and FDR (Figure 1). In each sce-
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each associated with expression levels of a target gene. We
performed eQTLmapping and evaluated a variety of multi-
ple testing correction methods, used both individually and
hierarchically, under each scenario.We next investigated the
accuracy of genetic effect size estimation across scenarios,
the effect of the Winner’s Curse, and how bias was affected
by study power. At last, we evaluated the accuracy of a va-
riety of eQTL effect size estimation procedures.
MATERIALS AND METHODS
Simulating genotypes and selecting eQTLs
Genotype data were simulated using HAPGEN2 (33) based
on the 99 FIN haplotypes of chromosome 22 from the 1000
Genomes Project data (phase3, GRCh37) (34). The simu-
lated genotypes had similar LD patterns with the reference
data. Six sets of genotype data were generated at varying
sample sizes: 100, 200, 500, 1000, 2000 and 5000 individu-
als. After filtering out SNPs with MAF <0.5% or Hardy–
Weinberg equilibrium P-value <5 × 10−6, ∼150 thousand
SNPs remained in each data set.
We explored six different true eSNP MAFs (0.5, 1, 5, 10,
25 and 50%) in each of the six genotype datasets, resulting
in 36 scenarios in total. In each scenario, 200 SNPs at the
scenarioMAFwere randomly chosen as true causal eSNPs,
each regulating the expression of a randomly selected cis
gene (within ±1 Mb from transcription start site (TSS) of
the gene). These 200 causal eSNPs were selected from an
LD pruned subset where the pairwise r2 was ≤0.3.
Simulating gene expression
To get a distribution of cis-eQTL effect sizes, we first per-
formed eQTL mapping in DILGOM dataset (35,36) using
additive linear model with covariates that accounted for
gender, age and population structure. Expression data were
further scaled to make each gene’s expression across sam-
ples follow a standard normal distribution. To avoid an in-
flated number of associations due to LD structure among
variants, we kept only the best association with the mini-
mum nominal P-value for each gene. As shown in simula-
tion results, only eQTLswith large effect sizes could be iden-
tified given a limited sample size. To reduce the bias caused
by limited power, we included all genes to obtain the effect
size distribution and fit it with a gamma distribution, from
which we randomly selected true effect sizes.
First, we performed a set of simulations in which the ex-
pression of 200 genes were simulated, each regulated by a
single causal eSNP, varying the study sample size, as well
as the MAF and effect size of the causal eSNP. In each sce-
nario, 200 genes out of 618 genes on chromosome 22 were
designated as ‘true eGenes’ regulated by a causal eSNP each
and the remaining 418 as ‘null genes’ with no truly associ-
ated eSNPs. The 200 true associations were modelled by a
simple linear regression:
yi = βgi + εi with εi ∼ N (0, 1) ,
where yi denoted the expression level of an eGene for indi-
vidual i, β the genetic effect size of the corresponding eSNP,
gi theminor allele dosage of the eSNP coded as 0, 1 or 2, and
εi the error variance for the ith individual, which followed
a standard normal distribution. For 418 null genes, no ge-
netic effects were simulated (β = 0) and the simulated ex-
pression was normally distributed. True eGenes effect sizes
were randomly drawn from a gamma distribution derived
from a real dataset as described above. In scenarios where
causal eSNPs had a constant effect size, β was 0.25, 0.5, 1
or 1.5.
Additional simulations were performed to examine the
consequences of the following for multiple testing correc-
tion: the assumption of error normality in the simulations,
correlation structure amongst gene expression, non-linear
eSNP effects and multiple causal eSNPs. In all simulations,
including those above, 100 replicates were performed to ob-
tain estimates of sensitivity and FDR under each scenario
for each multiple testing correction method described in the
next section below.
To examine the assumption of error normality, we simu-
lated gene expression as described above, but changing the
error term to be drawn from a log-normal distribution (with
mean and s.d. of the variable’s natural logarithm 0 and 1,
respectively). Simulations were additionally performed in
which gene expression profiles were inverse rank normal-
ized across samples using the ‘rntransform’ function in the
GenABEL R package (37).
To examine the effect of gene coexpression on eQTLmap-
ping, we simulated correlated expression amongst adjacent
genes arising from a single shared causal eSNP. Chromo-
some 22 was divided into 35 genomic blocks with a length
of 1 Mb. Two hundred true eGenes were randomly selected
from all 618 genes, and true eGenes within each genomic
block were simulated to have correlated gene expression lev-
els, sharing the same causal eSNP. Correlated expression y1,
y2, . . . , yi for each true eGene1, eGene2, . . . , eGenei in block
j were simulated as following:
y1 = β j × g j + ε1,
y2 = β j × g j + r2 × ε1 +
√
1 − r22 × ε2,
. . . ,
yi = β j × g j + ri × ε1 +
√
1 − ri 2 × εi .
All i true eGenes in this block shared a causal eSNPj,
which was coded as (0, 1, 2), and had the same geneti-
cally regulated component (β j × g j ) where β j was the ef-
fect size of the SNP on each true eGene. Error terms (ε1, ε2,
. . . , εi ) followed a standard normal distribution. For each
eGenei, except for the first eGene1, the noise component
(ri × ε1 +
√
1 − ri 2 × εi ) followed a standard normal distri-
bution that was correlated with the error term of the first
eGene1 (ε1) with a correlation coefficient ri , which was ran-
domly drawn from a uniform distribution U(0.6, 0.9).
To examine the effect of non-linear eSNPs on multi-
ple testing correction, two additional simulations were per-
formed. One in which all causal eSNPs had dominant ef-
fects, and the other in which all causal eSNPs had recessive
effects. To simulate dominant effects, causal eSNPs were
coded as (0, 2, 2) based on the absence/presence of one or
more copy of the minor allele. Conversely, to simulate re-
cessive effects, causal eSNPs were coded as (0, 0, 2). Apart
from the causal eSNP coding, simulations were as described
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randomly selected and simulated to have a single causal
eSNP with a standard normal error term.
To examine the effect of multiple causal eSNPs on multi-
ple testing correction, two additional simulations were per-
formed. One in which each true eGene was regulated by two
causal eSNPs, and one in which each true eGene was reg-
ulated by three causal eSNPs, with additive effects on gene
expression as follows:
Two causal eSNPs:
y = β1 × g1 + β2 × g2 + ε,
Three causal eSNPs:
y = β1 × g1 + β2 × g2 + β3 × g3 + ε,
where effect sizes β1, β2 and β3 were drawn from the gamma
distribution described at the start of the section based on
the distribution of effect sizes observed in a real dataset.
The terms g1, g2 and g3 describe the minor allele dosage of
the each causal eSNP, respectively. In each simulation, the
first causal eSNPwas randomly selected as described above,
based on the desired MAF for each scenario. Additional
causal eSNPs at each eGene were randomly selected from
nearby variants in LD with g1 based on the distribution
of LD correlation observed between multiple causal eSNPs
observed in a conditional eQTL study of ∼5000 peripheral
blood samples (38), following a beta distribution with the
shape parameters 2.6 and 4.5. Using this selection scheme,
MAFs tended to be similar across the multiple causal eS-
NPs at each eGene (Supplementary Figure S20). The error
term ε was drawn from a standard normal distribution as
described above.
Mapping eQTLs and correcting for multiple testing
For cis-eQTL analysis, we used Matrix eQTL (39) to fit lin-
ear regression models between each gene and the minor al-
lele dosage of all SNPs located within 1 Mb of the gene’s
TSS. To adjust for multiple tests, we applied either (i) a cor-
rection method to all hypotheses (pooled method) or (ii) a
hierarchical correction procedure, where two methods were
used in combination to correct for multiple SNPs tested for
each gene and multiple genes separately.
Pooled multiple testing correction was performed us-
ing either Bonferroni correction or FDR-controlling proce-
dures applied to all SNP–gene hypothesis tests. Bonferroni
correction (pooled Bonferroni), Benjamini and Hochberg
(17) (pooled BH) and Benjamini and Yekutieli (18) (pooled
BY) FDR procedures were performed using ‘p.adjust’ func-
tion in R (40), and Storey and Tibshirani (19) (pooled ST)
procedure was performed by the R package ‘qvalue’ (41).
A three-step procedure was employed to perform hierar-
chical multiple testing correction. In Step 1, P-values of all
cis-SNPs were adjusted for multiple testing for each gene
separately (locally adjusted P-value). In Step 2, the mini-
mum adjusted P-value from Step 1 was taken for each gene,
then these adjusted P-values were further adjusted for mul-
tiple testing across all genes (globally adjusted P-value). At
last, in Step 3, significant eSNPs were identified for each sig-
nificant eGene as SNPswith a locally adjustedP-value from
Step 1 lower than the locally adjusted minimum P-value
corresponding to the globally adjustedP-value threshold of
0.05.
Hierarchical multiple testing correction was performed
using different combinations of multiple testing correction
methods in Step 1 and Step 2 described above. In Step 1,
we applied FDR procedures (ST, BH or BY), Bonferroni,
eigenMT (22) or permutation approaches to correct for
multiple local SNPs tested for each gene. In Step 2, we ap-
plied three FDR-controlling procedures or Bonferroni cor-
rection to control the rate of false positive eGenes. Note that
eigenMT and permutation approaches are used hierarchi-
cally by design.
When Bonferroni was used as a local correction method,
the adjustedP-value was calculated bymultiplying each lin-
ear model P-value by the number of SNPs in the corre-
sponding 1 Mb cis window for the tested gene. When using
eigenMT, the linear model P-value was multiplied by the
number of effective independent tests estimated from the
genotype correlation matrix by eigenMT (in Python 2.7.3)
(22). Permutations were performed by shuffling sample la-
bels of expression data. For each gene, minimum nominal
P-values from all permutation tests were kept to obtain the
null distribution. Permutation P-values were calculated as
the proportion of permutations showing more significant
minimum P-value than the observed nominal P-value. The
null distribution used to calculate permutationP-values was
either (i) the exact distribution from permutations (exact
permutation scheme) or (ii) a beta distribution approxima-
tion of the null distribution tail, which is implemented in
FastQTL (version 2.0) (20). When using FastQTL, we per-
formed either a fixed number of permutations (1000) or
under an adaptive scheme, a number ranging from 100 to
10 000 permutations determined via iterative estimates of
gene significance throughout the permutation procedure.
When calculating the sensitivity and FDR of multiple
testing correction methods, true positives and false discov-
eries were calculated at the gene level. If any significant
SNPs were in high LD (r2 ≥ 0.8) with any simulated causal
eSNP, an eGene was considered a true positive. Conversely,
if there were significant SNPs for an eGene but it was not
simulated to be a true eGene or no significant SNPs were in
high LD (r2 ≥ 0.8) with any simulated causal eSNP, it was
considered a false discovery.
Conditional analyses
In simulations of multiple causal eSNPs, a two-stage condi-
tional analysis (42) was performed to identify independent
eSNPs for each significant eGene after eQTL mapping and
hierarchical multiple testing correction with eigenMT-BH.
The nominal P-value threshold corresponding to the global
correction FDR 0.05 cut-off calculated via eigenMT-BH in
the initial eQTL scan was used to determine significance in
the conditional analysis.
The conditional analysis comprised two stages: a forward
stage and a backward stage. The forward stage consisted
of an iterative procedure. At each iteration, cis-eQTL map-
ping was performed for each significant eGene, adjusting
for the top SNP identified in the initial eQTL mapping. If
any SNPs remained significant after adjusting for this top
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dent eQTL signals and adjusted for in subsequent iterations.
If no SNPs were significant, the iterative procedure termi-
nated and proceeded to the backward stage. In the back-
ward stage, each independent eQTL signal was tested sep-
arately using a leave-out-one model adjusting for all other
SNPs in the list of independent eQTL signals as covariates.
The final set of independent eQTLs comprised the set of eS-
NPs that remained significant in the backward stage.
When calculating the sensitivity and FDR of the condi-
tional analyses, each independent eQTL signal was consid-
ered a true positive if it was in high LD (r2 ≥ 0.8) with any
simulated causal eSNP. Conversely, an independent eQTL
signal was considered a false discovery if it was not in high
LD with any simulated causal eSNP. Where two or more
independent eQTL signals were identified and in high LD
with any causal eSNP, only one signal was considered a true
positive while all others were considered false discoveries.
Correcting for Winner’s Curse
To evaluate and correct the effect of the Winner’s Curse, we
considered the effect size estimates of the SNPwith themin-
imum P-value (top eSNP) for each eGene. We use βˆN(e) to
denote the ‘naı¨ve estimator’: the beta coefficient obtained
from the linear regression of each eGene on its top eSNP.
We adjusted a bootstrap method (43) to re-estimate
eQTL effect sizes of significant eGenes determined by a hi-
erarchical correction procedure (Bonferroni-BH by default;
eigenMT-BH is also recommended). This approach consists
of a repeated bootstrap analysis, in which random samples
are drawn with replacement from the study dataset to par-
tition the study samples into two groups: a bootstrap de-
tection group of identical size to the original dataset com-
prising samples randomly selected with replacement and a
bootstrap estimation group comprising the remainder of
the study samples. Due to the sampling with replacement,
the bootstrap detection group typically comprised 63.2%
of the study samples while the bootstrap estimation group
comprised the other 36.8% of samples. The effect size is then
estimated separately in the bootstrap detection and estima-
tion groups for each eGenes and its top eSNP based on the
original dataset.
After performing the above procedure with 200 boot-
straps, three bootstrap estimators were calculated and com-













i = 1 βˆE(e)i ;
and a weighted estimator:
(1 − ω) βˆN(e) + ω 1B(e)
∑B(e)
i = 1 βˆE(e)i .
Where βˆD(e)i denotes the effect size of eGene e in each
bootstrap detection group i, βˆE(e)i denotes the effect size
of eGene e in each bootstrap estimation group i and B(e)
denotes the number of bootstraps in which the association
between the eGene e and its top eSNP was significant in
the bootstrap detection group (thus B(e) ≤ 200). An associ-
ation between an eGene and its top eSNP was considered
significant in the bootstrap detection group if its locally ad-
justedP-value (corrected formultiple cis-SNPs within 1Mb
of the respective eGene using e.g. eigenMT or Bonferroni)
was smaller than the locally adjusted P-value correspond-
ing to the 0.05 threshold after global adjustment (e.g. BH) in
the eGene detection analysis prior to performing the boot-
strap procedure. For the weighted estimator, the weight w
was 0.632, i.e. the proportion of unique samples in the boot-
strap detection group.
RESULTS
Simulation of cis-eQTL data
To assess the power, FDR and effect size estimation of
eQTL studies based on different parameters, we simulated
36 scenarios with combinations of six sample sizes (N =
100, 200, 500, 1000, 2000 and 5000) and six true minor al-
lele frequencies (MAFs) of eSNPs (MAF = 0.5, 1, 5, 10,
25 and 50%). Realistic LD patterns were simulated using
HAPGEN2 (33) with chromosome 22 of the 1000Genomes
Project phase 3 data (34) as reference. In each scenario,
618 gene expression traits were simulated, among which
200 were under genetic regulation (true eGenes). Each true
eGene was simulated to be regulated by one cis-eQTL with
a genetic effect size randomly drawn from an empirical dis-
tribution based on eQTL analysis of a real dataset (35,36).
For each gene, all SNPs located within 1Mb of the TSS
were tested for association using linear regression mod-
els through Matrix eQTL (39). We mapped cis-eQTLs for
the 36 scenarios separately and evaluated different mul-
tiple testing correction methods. Figure 1 illustrates the
workflow of our eQTL simulations and methods evalu-
ation. We used Bonferroni, FDR-controlling procedures,
permutation approaches and eigenMT to correct for mul-
tiple testing. The Bonferroni and FDR procedures were ap-
plied alone to all hypotheses (pooledmethod) and were also
used in combination via a hierarchical correction procedure
(‘Materials andMethods’ section). We repeated the simula-
tion for each scenario 100 times and calculated the sensi-
tivity and FDR of each multiple testing correction method
based on all simulations.
Power and false discovery rate between scenarios andmultiple
testing correction procedures
We first assessed the variability in sensitivity and FDR for
the various multiple testing correction methods for eGene
detection across simulation scenarios. A significant eGene
was considered a true positive if: (i) it was among the 200
true eGenes simulated, and (ii) the simulated causal eSNP
for that eGene was among the significant eSNPs, or a signif-
icant eSNP was in high LDwith the causal eSNP (r2 ≥ 0.8).
For each multiple testing correction method, sensitivity, or
true positive rate (TPR), was calculated as the proportion of
simulated true eGenes correctly identified as true positives.
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false positives in significant eGenes identified across all 100
simulations.
We evaluated multiple testing correction methods in two
ways: first, applied across all SNP–gene hypothesis tests
(hereby ‘pooled methods’) and second, in combinations
in a hierarchical approach in which SNP–gene hypothe-
sis tests were partitioned into groups by the gene being
tested (hereby ‘hierarchical correction procedures’) (44). In
the case of hierarchical correction procedures, the multiple
hypothesis tests of eGenes were controlled (Step 2, global
correction) based on the multiple testing adjusted statis-
tics (Step 1, local correction) of each gene’s best associa-
tion, then SNPs significantly associated with the significant
eGenes were identified based on the locally corrected P-
value corresponding to the threshold of 0.05 after global
correction (Step 3, ‘Materials and Methods’ section).
FDR-controlling procedures applied to all hypotheses
(pooled FDR methods) failed to control the FDR of
eGenes in nearly all scenarios (Supplementary Figure S1).
We applied three FDR-controlling procedures to all hy-
potheses: the Storey and Tibshirani (ST) (19), Benjamini
and Hochberg (BH) (17) and Benjamini and Yekutieli (BY)
(18) procedures. The ST and BH procedures failed to con-
trol FDR at the desired level of 0.05 in majority of the
scenarios, and FDR increased with sample size, reaching
more than 0.6 under scenarios with sample sizes of 2000 or
5000 and true eSNP MAFs ≥25% (Supplementary Figure
S1A). The BY procedure was the most conservative method
among pooled FDR procedures but still had inflated FDR
under scenarios with large sample sizes (≥1000) and true
eSNPMAFs ≥25%. As expected, a pooled Bonferroni cor-
rection had very lowFDRvalues inmost scenarios, with the
lowest sensitivity across MAFs and sample sizes (Supple-
mentary Figure S1). However, even pooled Bonferroni cor-
rection failed to control FDR of rare variant eQTLs (MAF
≤1%) in scenarios with <1000 samples. Overall, we ob-
served inflated rates of false positive eGenes for all pooled
FDR methods.
In contrast to pooled methods, we observed better cali-
bratedFDR for hierarchicalmultiple testing correction pro-
cedures, except in scenarios with low statistical power ( Fig-
ure 2A and Supplementary Figure S2). We compared ST,
BH, BY, Bonferroni, eigenMT and three permutation ap-
proaches (discussed in a later paragraph) for adjusting the
cis-SNPP-values for each simulated gene (local correction),
combined with a comparison of the ST, BH, BY and Bon-
ferroni correction for adjusting the subsequent minimum
adjusted P-value across all genes (global correction).
We observed lower sensitivity as well as lower FDR than
ST and BH when applying BY and Bonferroni to correct
across genes, regardless of which multiple testing correction
method was used for local correction (Supplementary Fig-
ures S2 and S3). ST and BH global correction had identical
performance, except when permutation tests were used as
local correction method, where ST had higher FDR than
BH and often had FDR slightly higher than 5% (Supple-
mentary Figures S2 and S3). We therefore subsequently fo-
cused on the BH procedure to control for multiple testing
across genes in hierarchical correction procedures.
We compared three different permutation approaches to
correct for multiple testing at each gene: (i) using exact per-
mutation test P-values from 1000 permutations (Perm1k-
BH), (ii) using P-values obtained from beta distribution
approximation of each null distribution’s tail after 1000
permutations (BPerm1k-BH) and (iii) using beta approx-
imation under an adaptive scheme where a minimum of
100 and a maximum of 10 000 permutations were per-
formed for each gene based on the significance level of
this gene (APerm10k-BH). Due to the prohibitive computa-
tional time required to run Perm1k and APerm10k, we ran
10 simulations rather than 100 to compare the three permu-
tation approaches. Perm1k-BH had lower sensitivity than
the other two permutation approaches in scenarios with low
detection power and it also had a higher FDR (Supplemen-
tary Figure S4). BPerm1k and APerm10k had similar per-
formance, indicating 1000 permutations were sufficient to
obtain an accurate approximation of the P-value null dis-
tribution tail. We therefore used BPerm1k-BH as a repre-
sentative of permutation approaches to compare with other
multiple testing correction methods.
Amongst the hierarchical correction methods with BH
as global correction, BY adjustment of multiple SNPs (BY-
BH) had the most conservative FDR among all methods,
more so than Bonferroni-BH due to BY’s heavier correc-
tion for the lowest P-values; however, this came at the ex-
pense of lower sensitivity (Figure 2). Besides BY-BH, other
methods did not show a notable difference in sensitivity.
Perhaps surprisingly, Bonferroni-BH maintained a compa-
rable sensitivity to othermethods while having an FDRwell
below 0.05. In terms of calibration, eigenMT-BH had an
FDR closest to 0.05 and was relatively stable with respect
to sample size, whereas other methods showed an inverse
relationship between FDR and sample size. In the ‘Discus-
sion’ section, we explore the trade-offs of FDR calibration
versus minimization for a given power. Below, we utilize the
eigenMT-BH procedure to illustrate the ramification of our
findings for eQTL study design, while also noting that de-
sign differences between Bonferroni-BH and eigenMT-BH
would be minor.
These observations were robust under a variety of more
complex simulations. Relative performance of hierarchi-
cal multiple testing procedures in terms of FDR calibra-
tion and sensitivity remained the same when simulating
(i) log-normal noise (‘Materials and Methods’ section ;
Supplementary Figure S5), (ii) correlated expression via a
shared causal cis-SNP (‘Materials and Methods’ section
; Supplementary Figure S6), (iii) dominant and recessive
causal SNPs (‘Materials and Methods’ section ; Supple-
mentary Figures S7 and S8) and (iv) multiple causal cis-
SNPs per eGene (‘Materials and Methods’ section ; Sup-
plementary Figure S9). However, there were notable sce-
narios where FDR was inflated above 5%. Simulations of
log-normal noise without inverse normal transformation
resulted in FDR approaching 1.0 due to pervasive outliers,
produced by extreme noise that coincided with low MAF
variants (Supplementary Figure S10). Simulations of cor-
related gene expression (Supplementary Figure S6) showed
reduced FDR control at low power across all methods com-
pared to uncorrelated gene expression.
Across all effect sizes and using the eigenMT-BH proce-
dure (Figure 2), it was apparent that (i) eSNPs with ≤0.5%
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Figure 2. FDR and sensitivity of selected hierarchical multiple testing correction methods. Comparison of the FDR (A) and sensitivity/TPR (B) of six
methods (different colours) for controlling multiple testing of SNPs at each gene (local correction), with BH used to control for multiple testing across
all genes (global correction). The six methods compared were Storey and Tibshirani (ST), Benjamini and Hochberg (BH), Benjamini and Yekutieli (BY),
Bonferroni correction, eigenMT and permutation tests based on beta approximation (BPerm1k). Comparison of all combinations of multiple testing
correction methods for hierarchical correction is shown in Supplementary Figures S2 and S3. Application of BH in the global correction step had the
best sensitivity for all methods used in the local correction step of any hierarchical correction procedures. Each dot represents one scenario and plots
show different MAFs of the simulated causal eSNPs. The dashed horizontal lines in panel (A) indicate the desired FDR level of 5%. Scenarios where no
significant eGenes were identified are not shown in panel (A).
samples, respectively, were likely to be false discoveries, (ii)
for studies with 100 samples, a MAF threshold of 10% is
necessary to control FDR at ≤5% irrespective of hierar-
chical multiple testing procedure. Recessive eSNPs detected
with standard eQTL analyses (i.e. using linear models) were
largely false discoveries when MAF was ≤25% in 100 sam-
ples or MAF ≤10% in up to 1000 samples (Supplementary
Figure S8). In varying the eSNP effect size (0.25, 0.5, 1.0
or 1.5 s.d. gene expression per allele), we found that sam-
ple sizes up to 200 (quite common in the eQTL literature)
only reached 80% power for eQTLs of ≥5% MAF and ef-
fect size 1.5 s.d. per allele or for eQTLs of 50% MAF and
effect size of approximately ≥0.6 s.d. per allele ( Figure 3).
The maximum sample size of 5000 in our simulations still
did not reach 80% power to detect eQTLs with effect size of
0.25 s.d. per allele and <5%MAF. When sample sizes were
>1000 and MAF >25%, eQTLs with effect size of 0.25 s.d.
per allele could be detected at power 80%. Studies of 100
samples were underpowered unless eQTLs were moderately
common (at least∼25%MAF) and of large effect size (≥1.0
s.d. per allele).
Identification of the simulated causal eSNP
When hierarchical multiple testing correction procedures
had calibrated FDR for eGenes, we observed multiple sig-
nificant eSNPs at each true positive eGene (Supplementary
Figure S11) despite simulating only one causal eSNP for
each true eGene, as would be expected given LD. The num-
ber of SNPs significantly associated with a true eGene in-
creased with both sample size and true eSNP MAF, with
>1000 significant eSNPs identified per eGene on average in
the scenario with the largest sample size (N = 5000), true
eSNP MAF (50%) and eQTL effect size (1.5 s.d. per allele)
(Supplementary Figure S11).
Many studies focus on the eSNP with the strongest asso-
ciation (lowest P-value) with each eGene (top eSNP) when
performing downstream analyses, such as enrichment anal-
ysis or effect size estimation (14,16). In our simulations, we
found that while the power to detect the presence of an
eQTL increased with increasing MAF, the probability that
the true causal eSNP was the top eSNP declined (Figure
4A). However, holdingMAF constant and increasing study
power (increasing sample size and effect size) resulted in in-
creasing probability to detect the true causal eSNP (Figure
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Figure 3. Power and eQTL effect size. A constant genetic effect size (0.25, 0.5, 1.0 or 1.5 s.d. gene expression per allele) was simulated in each scenario.
Plots represents different MAFs of the simulated true eSNPs. Sample size increases from left to right on x-axes. The estimated statistical power for eGene
detection from 100 simulations is shown on y-axes. A hierarchical correction procedure using eigenMT for local correction and BH for global correction
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Figure 4. Identification of true causal eSNPs. In each scenario, the 200 causal eSNPs have the same effect size in addition to MAF. For significant true
eGenes, the proportion of top eSNPs (minimum P-value) that were true causal eSNPs (or in perfect LD) is shown (y-axes) for either (A) the power to detect
eQTLs of the scenario or (B) the amount of LD for true causal eSNPs, i.e. the average number of SNPs within 1Mb and in moderate LD (r2 ≥ 0.5) with
the causal eSNP. Scenarios are coloured according to true eSNP MAF. Only scenarios with power ≥0.01 are shown. A hierarchical correction procedure
using eigenMT for local correction and BH for global correction (eigenMT-BH) was used to identify eGenes.
top eSNPs with MAF 0.5% were nearly always the true
causal eSNP. Given the critical role of LD in fine-mapping,
we confirmed our observations were due to a positive rela-
tionship between an eSNPs’ MAF and the amount of local
LD (Figure 4B). For top eSNPs that were not true causal eS-
NPs, 83%were in high LD (r2 ≥ 0.8) with the true causal eS-
NPs (Supplementary Figure S12). Overall, for studies with
80% power to detect a given eQTL of MAF ≤25%, the top
eSNP was the true causal eSNP 90% of the time.
We next investigated the sensitivity and FDR of typi-
cal conditional analyses to identify and distinguish between
multiple causal eQTL signals, using the nominal eSNP sig-
nificance P-value threshold determined by eigenMT-BH
correction (‘Materials and Methods’ section). FDR among
independent eQTL signals identified by conditional analy-
ses decreased as sample size increased (Supplementary Fig-
ure S13). FDRwas slightly inflatedwhenmultiple causal eS-
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sistent with the inflated FDR observed in the initial eQTL
scan (Supplementary Figure S9), because of the presence
of negatively correlated minor allele dosages between the
causal eSNPs of an eGene, which was more often observed
when causal eSNPs hadMAFs of 50% (Supplementary Fig-
ure S14). In scenarios where MAFs of causal eSNPs were
≥25%, conditional analyses identified additional causal eS-
NPs that were not significant in the initial eQTL mapping
step (Supplementary Figure S15). Among the top SNPs (at
each independent locus)≥80%were the causal eSNPs (or in
perfect LD) when causal eSNPs had MAF of ≤25% (Sup-
plementary Figure S16). The proportion was lower when
MAF of causal eSNPs were 50%, consistent with scenarios
with a single simulated causal eSNPs (Figure 4A).
Winner’s Curse in eQTL effect size estimation
To systematically evaluate the effect of Winner’s Curse in
eQTL studies, we compared beta coefficients obtained from
theMatrix eQTL linear regression models for the top eSNP
of each true positive eGene (the ‘naı¨ve estimator’) to their
simulated true effect sizes. We observed that median error
of the naı¨ve estimator increased as study power decreased,
as expected, and also that the naı¨ve estimator consistently
overestimated the true effect size with overestimation in-
creasing as power to detect an eQTL decreased (Figure 5
and Supplementary Figure S17).
To address this, we investigated various methods for re-
estimating effect sizes. Methods have been proposed to cor-
rect forWinner’s Curse in GWAS (27,45), but to our knowl-
edge, no method has yet been designed for bias correc-
tion in eQTL studies. We adapted a bootstrap method (43)
for eQTL studies and compared three bootstrap estimators
(a shrinkage estimator, an out-of-sample estimator and a
weighted estimator, see ‘Materials and Methods’ section)
to determine the best approach for adjusting for Winner’s
Curse. All three bootstrap estimators had more accurate ef-
fect size estimates (smaller mean squared error and median
error closer to 0) than the naı¨ve estimator when power of
eQTL detection was low to moderate (Figure 5B and Sup-
plementary Figure S18). Amongst the three bootstrap esti-
mators, the shrinkage estimator was closest to the true ef-
fect size overall and across all study powers. In scenarios
with high power for eQTL detection, Winner’s Curse was
not apparent, and the bootstrap shrinkage estimator and
naı¨ve estimator had similar estimates (Supplementary Fig-
ure S19). The bootstrap method for eQTL studies is freely
available at https://github.com/InouyeLab/BootstrapQTL.
DISCUSSION
In this study, we have utilized extensive, realistic simula-
tions of eQTL data to investigate fundamental questions in
eQTL study design relating to power, FDR and effect size
estimation. The most commonly used MAF cut-offs in re-
cent eQTL studies are 1 or 5% (Supplementary Table S1).
For instance, GTEx restricted the association tests to SNPs
withminor allele count≥10 in the tissue analysed, the corre-
spondingMAF being 7 and 1.4%, in the minimum (70) and
the maximum (361) sample size, respectively (16). In our
simulations, we found that eQTLs with a small MAF iden-
tified in low sample sizes were highly likely to be false pos-
itives, regardless of which multiple testing correction strat-
egy was used (Figure 2; Supplementary Figures S1A and
S2). Based on above, when 100, 200 and 500 samples are
available (typical in eQTL studies), we recommend a MAF
cut-off at 10, 5 and 1%, respectively. Many studies listed in
Supplementary Table S1 had a lowerMAF cut-off than rec-
ommended. Detecting rare eQTLs with MAF 0.5% is pos-
sible in ≥2000 samples, but even 5000 samples cannot pro-
vide sufficient power unless the eQTL effect size is extremely
high: ≥1 s.d. gene expression per allele dosage (Figures 2
and 3).
Recent eQTL studies have used pooled FDR methods
to correct for multiple testing (46–50). Here, we show that
pooled methods are inappropriate for eQTL studies, as they
give inflated (sometimes substantially) FDR that worsen as
sample size or eSNP MAF increases (Supplementary Fig-
ure S1). This suggests that many eQTLs identified in these
studies may be false positives. Hierarchical multiple testing
correction procedures had substantially better calibrated
FDR. A hierarchical approach of permutation as local cor-
rection method followed by ST global adjustment is com-
monly used in eQTL studies (e.g. by GTEx (16)). When per-
mutation was used as a local correction method, ST often
had FDR slightly higher than the desired level in our simu-
lations, while use of BH insteadwould have better calibrated
FDR. Notably, ST and BH adjustment of multiple genes
after correction for multiple local SNPs at each gene using
other methods, except permutation tests, had identical re-
sults; therefore, we recommend using BH to adjust across
genes rather than ST.
Most hierarchical procedures had nearly identical sen-
sitivity when BH was used to correct for multiple testing
across genes, thus FDR was a differentiating factor (Fig-
ure 2). Here, when studies were appropriately powered,
eigenMT-BH was the most closely calibrated approach for
controlling FDR at 5%, and it had the least variable FDR
across different sample sizes. Although eigenMT-BH had
FDR inflated above 5% in our simulations of proximal cor-
related genes and recessive causal eSNPs (Supplementary
Figures S6A and S8A), these simulations represent worst
case scenarios rather than realistic data. We expect only
a fraction of eQTLs to comprise recessive effects, nor do
we expect all causal eSNPs to regulate all genes, which
are highly correlated, within a 1Mb window. Thus, we ex-
pect eigenMT-BH should control FDR at 5% in real eQTL
datasets. On the other hand, Bonferroni-BH had the small-
est FDRwith negligibly lower sensitivity. The trade-offs be-
tween the use of Bonferroni-BH versus eigenMT-BH are
best considered in the context of the specific study. Sta-
tistically, calibration is perhaps the deciding factor if the
analysis is intended to guide time-consuming experimental
follow-up of specific eQTLs, then it may be preferable to
minimize FDR for a given detection power.
After eGene detection, identification of the causal eSNP
among the significant eSNPs with high LD remains a chal-
lenge. Interestingly, we found that themost significant eSNP
was the simulated causal eSNP∼90% of the time.When the
top variant was not the causal variant,∼80% of the time the
top eSNP was in high LD (r2 ≥ 0.8). The proportion of sen-
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Figure 5. Winner’s Curse in eQTL effect size estimation and correction by bootstrap method. Panel (A) shows the phenomenon ofWinner’s Curse by three
examples: scenarios where the sample size is 200 and the MAFs of causal eSNPs are 5, 10 and 25%. Each dot represents one true positive eGene from
10 simulations of the scenario. Plots compare the estimated effect size (y-axes) of the top SNP of each true positive eGene to the true effect size (x-axes)
of the simulated causal eSNP. Red points show the naı¨ve estimator (beta coefficient from liner regression) and blue points show the bootstrap shrinkage
estimator, which was the best estimator (see panel (B)). Red (or blue) lines are linear regression fit of the naı¨ve estimator (or the bootstrap estimator) on
the simulated effect size for the true positive eGenes. Black dashed lines in panel (A) indicate where the estimated effect size equals to the true value. Panel
(B) shows the median error (difference between estimated and true effect size) for all estimators across 10 simulations of scenarios where a constant true
effect size (0.25, 0.5, 1 or 1.5 s.d. gene expression per allele) was simulated. A hierarchical correction procedure using eigenMT for local correction and BH
for global correction (eigenMT-BH) was used to correct for multiple testing.
80%, in conditional analyses applied in simulations of mul-
tiple causal eSNPs, motivating the use of fine-mapping ap-
proaches when there is evidence for multiple independent
causal eSNPs.
Winner’s Curse in eQTL effect size estimation must be
taken into account when comparing effect sizes from differ-
ent tissue types or conditions, estimating replication sample
size, or constructing predictive models. For example, a re-
cent study compared cis-eQTL effects between blood sam-
ples (N= 1240 samples) and four other tissues (N< 85 sam-
ples), identifying >2000 probes with cis-eQTL associations
that were tissue-dependent, and nearly half were with the
same eSNP but with a different effect size (51). This may be
an artefact of Winner’s Curse. To address eQTL effect over-
estimation, we have presented a bootstrap method and tool
for re-estimation, which should enable more accurate eQTL
comparisons as well as predictive genetic models for gene
expression for less accessible tissues, cell types, conditions
or other situations where power is limited.
Since most eQTL studies focus on cis-eQTL mapping,
there are limited findings of trans-eQTLs, thus realistic sim-
ulation of trans-eQTL datasets remains a challenge. Many
of the multiple testing correction methods evaluated in our
simulations are designed for cis-eQTL mapping only, such
as those involving FastQTL and eigenMT. To deal with the
multiple testing problem in trans-eQTL analysis, permuta-
tions would be time consuming for a whole genome scan,
and one might consider estimating the number of indepen-
dent gene expression traits and applying a Bonferroni cor-
rection. In terms ofWinner’s Curse in effect size estimation,
the bootstrap approach to reduce the upward bias would
still be applicable in a trans-eQTL setting.
The investigation of the genetic component of transcrip-
tional variation has become an essential part of linking
genotype to phenotype (52). Despite the increasing scale of
eQTL studies (e.g. 5257 samples in Yao et al. (6) and 2116
in Zhernakova et al. (14)), fundamental questions about
study design and analysis strategies have remained unan-
swered. Here, we have investigated the sensitivity and FDR
of diverse multiple testing strategies, the factors contribut-
ing the identification of the causal eSNP and the correc-
tion of eQTL effect size overestimation using a simple tool,
BootstrapQTL. The insights from our simulation study are
likely not limited to eQTL analysis and may extend to other
studies of genome-related quantitative traits, such as chro-
matin accessibility, methylation and other epigenetic traits.
SUPPLEMENTARY DATA
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